Metastatic basal cell carcinoma with amplification of PD-L1: exceptional response to anti-PD1 therapy.
about
Basal cell carcinoma: PD-L1/PD-1 checkpoint expression and tumor regression after PD-1 blockade.Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers.Exceptional Response to Nivolumab and Stereotactic Body Radiation Therapy (SBRT) in Neuroendocrine Cervical Carcinoma with High Tumor Mutational Burden: Management Considerations from the Center For Personalized Cancer Therapy at UC San Diego MooresAppearance of New Cutaneous Superficial Basal Cell Carcinomas during Successful Nivolumab Treatment of Refractory Metastatic Disease: Implications for Immunotherapy in Early Versus Late Disease.Dosing immunotherapy combinations: Analysis of 3,526 patients for toxicity and response patterns.Rare Tumor Clinic: The University of California San Diego Moores Cancer Center Experience with a Precision Therapy Approach.Emerging concepts and recent advances in basal cell carcinoma.Mutational patterns in chemotherapy resistant muscle-invasive bladder cancer.Genomic landscape of advanced basal cell carcinoma: Implications for precision treatment with targeted and immune therapies.A case of metastatic basal cell carcinoma treated with continuous PD-1 inhibitor exposure even after subsequent initiation of radiotherapy and surgery.
P2860
Q37713680-C0C8618E-83B8-4FAD-BCC4-EA62D798D0CBQ38611235-AB1054B7-E6EC-43DE-96E8-D677AABF0D71Q38760780-5C9A37BC-15B2-4666-8A72-2079469489E5Q42352191-791B0D78-4B54-48EE-AC24-1BB00C7FCC58Q44209463-DA845026-B834-4244-B948-F7C1BE9E2492Q46182953-07E98BF7-89FB-47A8-B07B-CC2CD58F483DQ47097802-706B694E-C943-4D99-9C71-3D3A2909EEF1Q47111129-2780FA48-85FF-4CA8-B4F2-216AB3B24F5FQ52733765-8C7617BA-09F7-474B-B94D-0B01C0BE4A92Q55082713-DA655C48-87D2-4B18-8447-7B4F1FA48777
P2860
Metastatic basal cell carcinoma with amplification of PD-L1: exceptional response to anti-PD1 therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Metastatic basal cell carcinom ...... response to anti-PD1 therapy.
@en
Metastatic basal cell carcinom ...... response to anti-PD1 therapy.
@nl
type
label
Metastatic basal cell carcinom ...... response to anti-PD1 therapy.
@en
Metastatic basal cell carcinom ...... response to anti-PD1 therapy.
@nl
prefLabel
Metastatic basal cell carcinom ...... response to anti-PD1 therapy.
@en
Metastatic basal cell carcinom ...... response to anti-PD1 therapy.
@nl
P2093
P2860
P1433
P1476
Metastatic basal cell carcinom ...... response to anti-PD1 therapy.
@en
P2093
Aaron M Goodman
Christopher K Ellison
Garrett Frampton
Philip R Cohen
Sadakatsu Ikeda
Sandip P Patel
Taylor J Jensen
Vincent Miller
P2860
P2888
P356
10.1038/NPJGENMED.2016.37
P577
2016-10-19T00:00:00Z
P6179
1041043239